Detalle Publicación

Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease

Autores: Avilés Olmos, Iciar; Dickson, John; Kefalopoulou, Zinovia; Djamshidian, Atbin; Kahan, Joshua; Ell, Peter; Whitton, Peter; Wyse, Richard; Isaacs, Tom; Lees, Andrew; Limousin, Patricia; Foltynie, Thomas
Título de la revista: JOURNAL OF PARKINSONS DISEASE
ISSN: 1877-718X
Volumen: 4
Número: 3
Páginas: 337-344
Fecha de publicación: 2014
Resumen:
While these data must still not be interpreted as evidence of neuroprotection, they nevertheless provide strong encouragement for the further study of this drug as a potential disease modifying agent in Parkinson's disease.
DOI: https://doi.org/10.3233/JPD-140364.
Impacto:
Google Scholar